Related Experiment Videos
[Determination of the alternative complement pathway in patients with amebic liver abscess]
Insights
Patients with amebic liver abscess show alternative complement pathway activation. Their sera contain a substance that activates the properdin pathway, though its significance remains unclear.
Area of Science:
- Immunology
- Infectious Diseases
Context:
- Amebic liver abscess is a serious condition caused by Entamoeba histolytica.
- The complement system plays a crucial role in innate immunity against pathogens.
Purpose:
- To investigate the activation of the alternative pathway of complement in patients with amebic liver abscess.
- To identify potential complement system dysregulation during invasive amebiasis.
Summary:
- The study examined sera from 11 patients with amebic liver abscess.
- Six of the 11 sera demonstrated activation of the alternative complement pathway.
- All sera exhibited reduced levels of total complement (CH50) and C3, despite normal C1q levels.
Impact:
- Suggests the presence of a substance in amebic liver abscess patient sera that activates the properdin pathway.
- Highlights potential complement system involvement in the pathogenesis of amebic liver abscess.
- Further research is needed to elucidate the precise role and significance of these findings.
Abstract:
The activation of the alternative pathway of complement in the sera of patients with amebic liver abscess was studied. Of 11 sera examined, only six showed an activation of the alternative pathway. However, all sera showed diminished levels of complement (CH50) and C3, in spite of normal levels of C1q. The results suggest that the sera of patients with invasive amebiasis have a substance capable of activating the properdin pathway. The significance of these observations is not completely clear at the present time.